Redefining
Cancer
Treatment
Redefining
Cancer
Treatment
Current average market price for omega-3 fatty acid supplements typically ranges from £10 to £30 for a month’s supply, depending on brand, concentration, and source.
Click 
Omega-3 fatty acids, particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are well-known for their health benefits, including heart health and brain function. However, they also have significant anticancer properties that make them a valuable component in cancer prevention and treatment strategies.
Anti-Inflammatory Effects: Omega-3 fatty acids exert anti-inflammatory effects, which are crucial in cancer prevention since chronic inflammation is a known risk factor for tumour initiation and progression13.
Induction of Apoptosis: Omega-3s have been shown to induce apoptosis (programmed cell death) in various cancer cell lines, including those from colorectal, pancreatic, prostate, and breast cancers. This action helps in reducing tumour growth and proliferation46.
Enhancement of Chemotherapy: Studies suggest that omega-3 fatty acids can enhance the effectiveness of chemotherapy by increasing the sensitivity of cancer cells to chemotherapeutic agents. This combination may improve treatment outcomes and reduce side effects34.
Synergistic Effects with Other Therapies: Omega-3s may also act synergistically with radiation therapy, potentially increasing tumour radiosensitivity6.
Colorectal Cancer: Omega-3s have been associated with reduced risk and improved survival in colorectal cancer, particularly when combined with other therapies12.
Breast Cancer: Omega-3s have shown potential in reducing breast cancer risk and improving outcomes by inducing apoptosis in breast cancer cells7.
Other Cancers: Omega-3s have demonstrated anticancer effects in various other cancers, including pancreatic, prostate, and lung cancers46.
Dietary Sources: Fatty fish like salmon, mackerel, and sardines are rich in EPA and DHA. Plant-based sources include flaxseeds and chia seeds, which contain alpha-linolenic acid (ALA), though it is less effective than EPA and DHA811.
Supplementation: For those unable to obtain sufficient omega-3s from diet alone, supplements can be beneficial. The recommended daily intake for general health is 250-500 mg of combined EPA and DHA912.
Omega-3 fatty acids offer promising anticancer properties, making them a valuable adjunct in cancer prevention and treatment strategies. Their ability to induce apoptosis, enhance chemotherapy efficacy, and reduce inflammation supports their potential role in metabolic therapy approaches for cancer management.
General Health: For general health, most health organisations recommend a minimum of 250-500 mg of combined EPA and DHA per day for adults15.
Therapeutic Benefits: For those seeking therapeutic benefits, such as lowering blood pressure or improving heart health, doses between 2,000-3,000 mg of EPA and DHA per day are often recommended25.
Maximum Safe Intake: The FDA and European Food Safety Authority (EFSA) suggest that up to 5,000 mg of combined EPA and DHA per day is generally safe, though higher doses are not typically recommended unless advised by a healthcare professional13.
It’s important to note that while higher doses can be beneficial for certain conditions, they may also increase the risk of side effects like blood thinning and excessive bleeding. Therefore, it’s advisable to consult a healthcare provider before starting high-dose omega-3 supplementation, especially if you have underlying health conditions or are planning surgery15.
Breast Cancer, Colorectal Cancer, Prostate Cancer
Omega-3 fatty acids, particularly those found in fish oil supplements, can cause several side effects, ranging from mild to severe.
Here are some of the most common side effects:
Gastrointestinal Issues:
Taste and Smell:
Other Symptoms:
Allergic Reactions:
Bleeding Risks:
Cardiovascular Effects:
Potential increase in atrial fibrillation risk at high doses11
To minimise side effects, it’s recommended to take omega-3 supplements with meals and consider splitting doses throughout the day. If side effects persist or worsen, consult a healthcare provider.
Several combination therapies involving omega-3 fatty acids have been studied, particularly in the context of cancer treatment and prevention.
Here are some examples:
Omega-3 Fatty Acids with Chemotherapy:
Omega-3s have been combined with chemotherapy to enhance treatment efficacy and reduce side effects. Studies suggest that this combination can protect against metastasis, improve therapeutic outcomes, and decrease the toxicity associated with conventional therapies15.
Omega-3s may increase the sensitivity of cancer cells to chemotherapeutic agents, allowing for potentially lower doses of these drugs6.
Stearidonic Acid (SDA) with Chemotherapy:
SDA, a plant-based omega-3 precursor, has been studied in combination with docetaxel (a chemotherapeutic agent) for prostate cancer. This combination showed synergistic effects in killing cancer cells while minimising toxicity to normal cells2.
Omega-3 Fatty Acids with Antioestrogens:
The combination of omega-3 fatty acids with antioestrogens like Tamoxifen has been proposed as a chemopreventive strategy for breast cancer. This approach may allow for lower, less toxic doses of antioestrogens while maintaining efficacy7.
Vitamin D and Omega-3 Fatty Acids:
A study combining vitamin D, omega-3 fatty acids, and a simple home exercise program found a cumulative reduction in cancer risk among older adults. This multi-component approach may offer a novel strategy for cancer prevention4.
These combination therapies highlight the potential of omega-3 fatty acids to enhance the effectiveness of various treatments while reducing side effects. However, further research is needed to fully explore their therapeutic potential.
Omega-3 fatty acids can have a positive impact on quality of life, particularly in individuals with chronic conditions. Here are some key findings related to their effects on quality of life:
Cancer Patients:
Studies have shown that omega-3 supplementation can improve quality of life in cancer patients, particularly those with advanced non-small cell lung cancer (NSCLC). Patients receiving omega-3s experienced better weight maintenance, reduced resting energy expenditure, and improved physical and cognitive function compared to those receiving standard care6.
Omega-3s may also enhance global health status and social function in cancer patients undergoing chemotherapy and radiotherapy6.
Chronic Obstructive Pulmonary Disease (COPD):
In patients with COPD, omega-3 supplementation has been associated with improved quality of life, reduced inflammation, and better exercise tolerance. Omega-3s may decrease the use of short-acting bronchodilators and reduce the number of exacerbations25.
While not all studies show significant improvements in quality of life scores, omega-3s generally contribute to a more favorable lipid profile and reduced inflammatory markers in COPD patients2.
General Health:
Omega-3s have anti-inflammatory properties, which can help reduce chronic inflammation associated with various diseases, potentially improving overall well-being and quality of life3.
They may also support mental health by alleviating symptoms of depression and anxiety, further enhancing quality of life3.
Omega-3 fatty acids can positively impact quality of life by improving physical and cognitive functions, reducing inflammation, and enhancing overall health status, particularly in individuals with chronic conditions like cancer and COPD. However, the extent of these benefits can vary depending on the specific condition and individual health status.
We’ve done our best to include as much information as possible for this supplement.
If you have any other questions, please send us a message or join our Skool Group and ask our knowledgeable and friendly community.
Omega-3 supplements are widely accessible over-the-counter in pharmacies, health food stores, and online retailers in the UK, EU, USA, Australia, and NZ. They are categorised as food supplements rather than pharmaceuticals in most countries.
Precise patient response rates related to omega-3 fatty acids were not identified in peer-reviewed literature.
The mechanisms behind potential resistance to the anti-cancer effects of omega-3 fatty acids are complex and multifaceted.
Here are some insights:
Altered Fatty Acid Metabolism:
Cancer cells often exhibit dysregulated fatty acid metabolism, which allows them to adapt and utilise alternative energy sources. This metabolic flexibility can reduce their responsiveness to omega-3-induced changes. For example, cancer cells may increase the expression of fatty acid transporters like CD36 to enhance exogenous fatty acid uptake, which can alter their lipid composition and metabolic dependencies16.
Inflammation:
Genetic Heterogeneity:
Tumour cell diversity, or genetic heterogeneity, can lead to some subpopulations being inherently less responsive to omega-3s. This variability in genetic makeup among cancer cells can influence how they metabolise and respond to omega-3 fatty acids, potentially rendering some cells resistant to their anticancer effects4.
Additional Factors:
PI3K/AKT/mTOR Pathway: Activation of this pathway can promote cancer cell survival and proliferation, potentially reducing the effectiveness of omega-3s. Omega-3s may inhibit this pathway, but its dysregulation in cancer cells could confer resistance4.
Lipid Signalling and Transport: Changes in lipid signalling and transport mechanisms, such as those involving CD36 and other fatty acid transporters, can influence how cancer cells respond to omega-3s16.
Cancer Stem Cells (CSCs): CSCs are often resistant to conventional therapies due to their self-renewal capabilities. While omega-3s have shown potential in targeting CSCs, their effectiveness may vary depending on the specific CSC population and tumour type4.
Understanding these factors can help in developing strategies to overcome resistance and enhance the anticancer effects of omega-3 fatty acids.
Preclinical studies on omega-3 fatty acids and their anticancer effects have provided valuable insights into their potential therapeutic applications.
Here’s an overview of some key findings from preclinical research:
Mechanisms of Action:
Apoptosis Induction: Omega-3 fatty acids, particularly EPA and DHA, have been shown to induce apoptosis (programmed cell death) in various cancer cell lines, including those from colorectal, breast, prostate, and pancreatic cancers5.
Anti-Inflammatory Effects: Omega-3s promote resolution of inflammation, which is crucial in cancer prevention and treatment, as chronic inflammation can contribute to tumour growth and progression25.
Endocannabinoid Metabolites:
A class of molecules formed when the body metabolises omega-3 fatty acids, known as endocannabinoids, has been found to inhibit cancer growth and spread. These molecules, such as endocannabinoid epoxides (EDP-EAs), have anti-inflammatory properties and can target the same receptors as cannabinoids, but without psychotropic effects13.
In osteosarcoma models, EDP-EAs slowed tumour growth, inhibited cancer cell migration, and caused cancer cell death13.
GPR120 and Immune System Modulation:
In prostate cancer models, the anticancer effects of omega-3 fatty acids were found to be dependent on the presence of functional GPR120 receptors in host bone marrow cells, not in tumour cells. This suggests that omega-3s modulate the immune system to exert their anticancer effects4.
Combination Therapies:
Preclinical studies have explored the potential of combining omega-3 fatty acids with conventional therapies to enhance their efficacy. Omega-3s may increase the sensitivity of cancer cells to chemotherapy, potentially improving treatment outcomes5.
Future Directions:
Overall, preclinical research supports the potential of omega-3 fatty acids as adjunctive therapies in cancer management, though more studies are required to translate these findings into clinical practice.
For more information, check clinicaltrials.gov.
Research has identified genetic markers that may influence the efficacy of omega-3 fatty acids in cancer treatment.
Here are some key findings:
Genetic Variants and Omega-3 Effects:
Studies suggest that omega-3 fatty acids, particularly EPA and DHA, interact with genetic variants to modulate cancer risk. For example, in prostate cancer, a greater intake of omega-3s was associated with lower cancer risk in individuals with specific genetic polymorphisms, such as the cyclooxygenase-2 (COX-2) single nucleotide polymorphism (SNP) rs46483102.
The effects of omega-3s may vary based on genetic background, affecting inflammatory pathways, oxidative stress, and tumour apoptosis2.
Personalised Therapeutic Approach:
The interaction between omega-3 fatty acids and genetic variants supports the development of personalised therapeutic regimens. Identifying specific genetic markers could help tailor omega-3 supplementation to maximise its anticancer benefits for individual patients2.
Gene-Diet Interactions:
In prostate cancer, omega-3 fatty acids have been shown to modulate tumour growth through Bad-dependent apoptosis, highlighting the importance of gene-diet interactions in cancer development4. This suggests that genetic factors can influence how effectively omega-3s work in cancer prevention and treatment.
While these findings are promising, more research is needed to fully understand how genetic markers affect the efficacy of omega-3 fatty acids in cancer therapy and to develop targeted therapeutic strategies.
Pterostilbene benefits include antioxidant and anti-inflammatory effects, with potential therapeutic applications in cancer, neuroprotection, and cardiovascular health. Learn more about
Could a humble heartburn pill hold the key to slashing cancer metastasis and boosting survival? Once relegated to pharmacy shelves
Website designed in collaboration with Simon Lown for Metabolic Therapy Ltd
Apoptosis, or programmed cell death, is a natural process where cells self-destruct when they are damaged or no longer needed. This is crucial for maintaining healthy tissues and preventing diseases like cancer.
Drugs and supplements that induce apoptosis help eliminate cancerous cells by triggering this self-destruct mechanism, ensuring that harmful cells are removed without damaging surrounding healthy tissue.
Understanding and harnessing apoptosis is vital in the fight against cancer, as it targets the root cause of the disease at the cellular level.
Cell proliferation is the process by which cells grow and divide to produce more cells. While this is essential for growth and healing, uncontrolled cell proliferation can lead to cancer.
Drugs and supplements that inhibit cell proliferation help prevent the rapid multiplication of cancerous cells, slowing down or stopping the progression of the disease.
By targeting the mechanisms that drive cell division, these treatments play a vital role in controlling and potentially eradicating cancer.
Cancer cells often hijack specific biological pathways to grow and spread. Drugs and supplements that target these pathways can disrupt the cancer cell’s ability to survive and multiply.
By focusing on the unique mechanisms that cancer cells use, these treatments can be more effective and cause fewer side effects compared to traditional therapies.
Targeting specific pathways is a key strategy in precision medicine, offering a tailored approach to combat cancer at its core.
Angiogenesis is the process by which new blood vessels form, supplying nutrients and oxygen to tissues. Cancer cells exploit this process to fuel their growth and spread.
Drugs and supplements that inhibit angiogenesis can effectively starve cancer cells by blocking the formation of these new blood vessels.
By cutting off the supply lines that tumors rely on, angiogenesis inhibitors play a crucial role in controlling and potentially shrinking cancerous growths.
Immunotherapy harnesses the power of the body’s immune system to combat cancer. By boosting or restoring the immune system’s natural ability to detect and destroy cancer cells, immunotherapy offers a targeted and effective approach to treatment.
Drugs and supplements that support immunotherapy can enhance the immune response, making it more efficient at identifying and attacking cancer cells.
This innovative approach not only helps in treating cancer but also reduces the risk of recurrence, providing a powerful tool in the fight against this disease.
Inflammation is the body’s natural response to injury or infection, but chronic inflammation can contribute to the development and progression of cancer.
Drugs and supplements with anti-inflammatory properties help reduce inflammation, thereby lowering the risk of cancer and other chronic diseases.
By targeting the inflammatory processes, these treatments can help maintain a healthier cellular environment and prevent the conditions that allow cancer to thrive.
